Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingevity (NGVT) Operating Leases (2019 - 2025)

Ingevity (NGVT) has disclosed Operating Leases for 7 consecutive years, with $133.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Leases fell 10.14% to $133.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $133.0 million, a 10.14% decrease, with the full-year FY2025 number at $133.0 million, down 10.14% from a year prior.
  • Operating Leases was $133.0 million for Q4 2025 at Ingevity, up from $20.9 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $156.0 million in Q4 2021 to a low of $20.9 million in Q3 2025.
  • A 5-year average of $54.1 million and a median of $40.2 million in 2023 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: crashed 73.85% in 2022, then surged 204.53% in 2024.
  • Ingevity's Operating Leases stood at $156.0 million in 2021, then plummeted by 73.85% to $40.8 million in 2022, then rose by 19.12% to $48.6 million in 2023, then soared by 204.53% to $148.0 million in 2024, then decreased by 10.14% to $133.0 million in 2025.
  • Per Business Quant, the three most recent readings for NGVT's Operating Leases are $133.0 million (Q4 2025), $20.9 million (Q3 2025), and $30.4 million (Q2 2025).